Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort.
Merel C BroersLuuk WieskeEce ErdagCemre GürlekCarina BunschotenPieter A van DoornFilip EftimovKrista KuitwaardJuna M de VriesMarie-Claire Y de WitMariska Mp NagtzaamSuzanne C FrankenLouisa ZhuManuela PaunovicMaurice de WitMarco Wj SchreursCinta LleixàLorena Martín-AguilarElba Pascual-GoñiLuis Antonio QuerolBart C JacobsRuth HuizingaMaarten J TitulaerPublished in: Journal of neurology, neurosurgery, and psychiatry (2023)
Distinguishing CIDP from AN is important, as patients with AN need a different treatment approach. Improvement and relapses were associated with changes in antibody titres, supporting the pathogenicity of these antibodies.